The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03): : 407 - 410
  • [12] Mitochondrial dysfunction in models of Alzheimer's disease
    Eckert, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 23 - 23
  • [13] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300
  • [14] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [15] Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
    Chris Cadonic
    Mohammad Golam Sabbir
    Benedict C. Albensi
    Molecular Neurobiology, 2016, 53 : 6078 - 6090
  • [16] Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
    Onyango, Isaac
    Khan, Shaharyar
    Miller, Bradley
    Swerdlow, Russell
    Trimmer, Patricia
    Bennett, James, Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 183 - 193
  • [17] Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease
    Reddy, P. Hemachandra
    BRAIN RESEARCH, 2011, 1415 : 136 - 148
  • [18] The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease
    Sanjib Guha
    Gail V. W. Johnson
    Keith Nehrke
    Molecular Neurobiology, 2020, 57 : 5103 - 5120
  • [19] The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease
    Guha, Sanjib
    Johnson, Gail V. W.
    Nehrke, Keith
    MOLECULAR NEUROBIOLOGY, 2020, 57 (12) : 5103 - 5120
  • [20] Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease:: the chickens or the eggs?
    Smith, MA
    Drew, KL
    Nunomura, A
    Takeda, A
    Hirai, K
    Zhu, XW
    Atwood, CS
    Raina, AK
    Rottkamp, CA
    Sayre, LM
    Friedland, RP
    Perry, G
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (06) : 527 - 531